On analysis of longitudinal clinical trials with missing data using reference-based imputation

被引:44
|
作者
Liu, G. Frank [1 ]
Pang, Lei [1 ]
机构
[1] Merck Res Labs, Late Dev Clin Biostat, 351 N Sumneytown Pike,UG1CD 44, N Wales, PA 19454 USA
关键词
Bayesian MCMC; longitudinal clinical trial; missing data; reference-based imputation; sensitivity analysis; MULTIPLE-IMPUTATION;
D O I
10.1080/10543406.2015.1094810
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Reference-based imputation (RBI) methods have been proposed as sensitivity analyses for longitudinal clinical trials with missing data. The RBI methods multiply impute the missing data in treatment group based on an imputation model built using data from the reference (control) group. The RBI will yield a conservative treatment effect estimate as compared to the estimate obtained from multiple imputation (MI) under missing at random (MAR). However, the RBI analysis based on the regular MI approach can be overly conservative because it not only applies discount to treatment effect estimate but also posts penalty on the variance estimate. In this article, we investigate the statistical properties of RBI methods, and propose approaches to derive accurate variance estimates using both frequentist and Bayesian methods for the RBI analysis. Results from simulation studies and applications to longitudinal clinical trial datasets are presented.
引用
收藏
页码:924 / 936
页数:13
相关论文
共 50 条
  • [1] Reference-based sensitivity analysis via multiple imputation for longitudinal trials with protocol deviation
    Cro, Suzie
    Morris, Tim P.
    Kenward, Michael G.
    Carpenter, James R.
    [J]. STATA JOURNAL, 2016, 16 (02): : 443 - 463
  • [2] Analysis of Longitudinal Clinical Trials with Missing Data Using Multiple Imputation in Conjunction with Robust Regression
    Mehrotra, Devan V.
    Li, Xiaoming
    Liu, Jiajun
    Lu, Kaifeng
    [J]. BIOMETRICS, 2012, 68 (04) : 1250 - 1259
  • [3] Missing Data Imputation With Baseline Information in Longitudinal Clinical Trials
    Zhang, Yilong
    Zimmer, Zachary
    Xu, Lei
    Lam, Raymond L. H.
    Huyck, Susan
    Golm, Gregory
    [J]. STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2022, 14 (02): : 242 - 248
  • [4] Reference-based multiple imputation for data missing not-at-random in cost-effectiveness analysis
    Leurent, Baptiste
    Gomes, Manuel
    Cro, Suzie
    Wiles, Nicola
    Carpenter, James
    [J]. TRIALS, 2019, 20
  • [5] Sensitivity analysis using an imputation method for missing binary data in clinical trials
    Proschan, MA
    McMahon, RP
    Shih, JH
    Hunsberger, SA
    Geller, NL
    Knatterud, G
    Wittes, J
    [J]. JOURNAL OF STATISTICAL PLANNING AND INFERENCE, 2001, 96 (01) : 155 - 165
  • [6] A causal modelling framework for reference-based imputation and tipping point analysis in clinical trials with quantitative outcome
    White, Ian R.
    Joseph, Royes
    Best, Nicky
    [J]. JOURNAL OF BIOPHARMACEUTICAL STATISTICS, 2020, 30 (02) : 334 - 350
  • [7] Reference-based multiple imputation for missing data sensitivity analyses in trial-based cost-effectiveness analysis
    Leurent, Baptiste
    Gomes, Manuel
    Cro, Suzie
    Wiles, Nicola
    Carpenter, James R.
    [J]. HEALTH ECONOMICS, 2020, 29 (02) : 171 - 184
  • [8] Control-Based Imputation and Delta-Adjustment Stress Test for Missing Data Analysis in Longitudinal Clinical Trials
    Liu, G. Frank
    Pang, Lei
    [J]. STATISTICS IN BIOPHARMACEUTICAL RESEARCH, 2017, 9 (02): : 186 - 194
  • [9] Missing data in clinical trials: control-based mean imputation and sensitivity analysis
    Mehrotra, Devan V.
    Liu, Fang
    Permutt, Thomas
    [J]. PHARMACEUTICAL STATISTICS, 2017, 16 (05) : 378 - 392
  • [10] Cost-effectiveness analysis of clinical trials with missing data: using multiple imputation to address data missing not at random
    Leurent, Baptiste
    Gomes, Manuel
    Carpenter, James
    [J]. TRIALS, 2017, 18